Tag: Sangamo Therapeutics
December 2, 2019
Top 10 Stem Cell Companies On The NASDAQ
The global stem cell therapy market is expected to grow at a CAGR of 36.52 percent between 2017 and 2021.... November 6, 2019
Sangamo to Present Gene Therapy and Ex Vivo Gene-Edited Cell Therapy Data
The company will present data at the 61st Annual Meeting of the American Society of Hematology in Orlando, Florida between...
April 29, 2018
5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent
Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 1, 2018
5 Top NASDAQ Biotech Stocks: Cardiome on Top
Cardiome, Avid, XBiotech, Fennec and Compugen were last week's five top-gaining NASDAQ biotech stocks. See what moved their share prices. March 18, 2018
5 Top NASDAQ Biotech Stocks: Second Sight Medical on Top
Second Sight, Juniper, Athersys, Aptose and ArQule were last week's five top-gaining NASDAQ biotech stocks. See what moved their share...
March 8, 2018
4 Gene Editing Technologies Explained
We look at four types of gene editing currently in clinical trials, as well as the pros and cons of... March 4, 2018